WASHINGTON (CBS.MW) -- Drug giant Glaxo SmithKline GSK, -2.27% is in talks with the Food and Drug Administration about selling its Fluarix flu vaccine in the United States to help with the looming ...
GlaxoSmithKline agreed on Sept. 17 to settle out of the first Zantac trial in California, which began this month in Oakland. GSK won two defense verdicts in Illinois earlier this year but faced 75,000 ...
Citi analyst Graham Parry maintained a Hold rating on GlaxoSmithKline today and set a price target of £22.50. Claim 30% Off TipRanks. Unlock hedge fund-level data and powerful in ...
The Globe and Mail: GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan
J.P. Morgan analyst Zain Ebrahim maintained a Sell rating on GlaxoSmithKline today and set a price target of £17.00. According to TipRanks, Ebrahim is ranked #10823 out of 12161 analysts. In addition ...
Drugmaker GlaxoSmithKline entered into a four-year collaboration with 23andMe to use human genetics to guide drug development, investing $300M in the direct-to-consumer genetic testing company to fund ...
JD Supra: GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
GlaxoSmithKline and Northwestern Sue Moderna for Patent Infringement in Trio of Lawsuits
GlaxoSmithKline (GSK) has released an update. GlaxoSmithKline (GSK) has announced that its issued share capital as of , consists of over 4.3 billion ordinary shares, with a total of ...
GlaxoSmithKline Pakistan Ltd. is a healthcare company, which engages in the manufacturing and marketing research-based vaccines, medicines, and consumer healthcare products. It operates through the ...
Reuters: India's GlaxoSmithKline Pharma posts first revenue drop in over two years